All Updates

All Updates

icon
Filter
Funding
Agrify to raise up to USD 1.84 million; exercising previously issued common stock warrants
Vertical Farming
Apr 19, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Vertical Farming

Vertical Farming

Apr 19, 2023

Agrify to raise up to USD 1.84 million; exercising previously issued common stock warrants

Funding

  • Agrify, a Nasdaq-listed company offering vertical farming solutions, has entered warrant inducement letters to raise up to USD 1.84 million in gross proceeds from the exercise of 10,651,430 common stock warrants issued in the company’s public offering in December 2022 or the existing warrants.

  • On April 18, 2023, Agrify had reduced the exercise price of all existing warrants from USD 0.65 per share to USD 0.1725 per share, and allowed certain investors to exercise 10,651,430 of their existing warrants at the reduced exercise price. The company will issue new warrants to such investors to purchase 200% of the shares exercised, which will become exercisable six months after issuance, have an exercise price of USD 0.1725, and a five-year term from their initial exercise date. If exercised in full, the warrants were expected to result in gross proceeds of USD 1.84 million for the company.

  • Analyst QuickTake: In 2022, the company raised USD 135 million through a senior-secured note facility , which included a restructuring of the terms to provide greater flexibility during a downturn in the cannabis industry. The company has, however, continued with its expansion plans. Earlier this month, it completed Phase I of Denver Greens' facility and announced plans to expand further in Phase II. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.